Clinical Trial

Adaptive Mechanisms In GRown up ObeSity Study (AMIGROS)

Study acronym: AMIGROS
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated October 4, 2023 (before its estimated December 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
The investigator recently showed that the glycan-binding adipokine galectin-1 increased during overfeeding and that galectin-1 independently could predict type 2 diabetes. Further, the molecules that induce insulin release in the fasting state when blood glucose is normal remain elusive. It is possible that galectin-1 is involved in adaptive mechanisms in adipose tissue in obese subjects.
Trial Details
NCT Number NCT06065930
Lead Sponsor Vastra Gotaland Region
Collaborators: Göteborg University
Conditions Obesity, Type 2 Diabetes
Enrollment 45 participants
Start Date 2023-05-05
Primary Completion 2025-12-31 (estimated)
Study Completion 2028-12-31 (estimated)
Updated on ClinicalTrials.gov 2023-10-04